Viking Therapeutics' experimental tablet helped reduce weight by as much as 3.3% in obese patients during a small early-stage study, meeting Wall Street expectations, and...
Receive email when new articles are published on -Viking Therapeutics' experimental tablet helped reduce weight by as much as 3.3% in obese patients during a small early-stage study, meeting Wall Street expectations, and sending the company's shares up 20% in premarket trading.
California-based Viking is one of several companies vying for a slice of the multi-billion dollar weight-loss drugs market. "We believe that an oral agent with good tolerability could represent an attractive potential treatment option for patients with obesity. We look forward to exploring longer treatment windows and potentially higher doses," Viking CEO Brian Lian said.
Before the data, at least two analysts had said they expected efficacy of between 2% and 5% in the trial.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Amazon Big Spring Sale 2024: tablet deals on Pixel Tablet, Galaxy Tab A9+, and many moreDay 2 of the Big Spring Sale at Amazon is already here. Check out today's top offers!
Read more »
Messenger RNAs with multiple 'tails' could lead to more effective therapeutics, say researchersMessenger RNA (mRNA) made its big leap into the public limelight during the pandemic, thanks to its cornerstone role in several COVID-19 vaccines. But mRNAs, which are genetic sequences that instruct the body to produce proteins, are also being developed as a new class of drugs.
Read more »
San Diego's latest biotech, Contineum Therapeutics, files to go publicContineum Therapeutics filed to go public, making it San Diego's second life science IPO of 2024
Read more »
Experimental weight loss pill seems to be more potent than OzempicTaking the oral pill amycretin resulted in people losing 13 per cent of their body weight over three months, more than twice that seen with Ozempic, but larger and longer studies are needed
Read more »
A New Headset Aims to Treat Alzheimer’s With Light and SoundAn experimental device developed by Cognito Therapeutics seeks to slow cognitive decline in Alzheimer’s patients using light and sound.
Read more »
March '24 Pixel Feature Drop is here for Pixel phones, Watch, and TabletJohanna 'Jojo the Techie' is a skilled mobile technology expert with over 15 years of hands-on experience, specializing in the Google ecosystem and Pixel devices. Known for her user-friendly approach, she leverages her vast tech support background to provide accessible and insightful coverage on latest technology trends.
Read more »